Related Experiment Video
Updated: Feb 8, 2026

Studying Pancreatic Cancer Stem Cell Characteristics for Developing New Treatment Strategies
Published on: June 20, 2015
Glutathione metabolism in cancer progression and treatment resistance
Ankita Bansal1, M Celeste Simon2,3
1Abramson Family Cancer Research Institute, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA.
Abstract:
Glutathione (GSH) is the most abundant antioxidant found in living organisms and has multiple functions, most of which maintain cellular redox homeostasis. GSH preserves sufficient levels of cysteine and detoxifies xenobiotics while also conferring therapeutic resistance to cancer cells. However, GSH metabolism plays both beneficial and pathogenic roles in a variety of malignancies. It is crucial to the removal and detoxification of carcinogens, and alterations in this pathway can have a profound effect on cell survival. Excess GSH promotes tumor progression, where elevated levels correlate with increased metastasis. In this review, we discuss recent studies that focus on deciphering the role of GSH in tumor initiation and progression as well as mechanisms underlying how GSH imparts treatment resistance to growing cancers. Targeting GSH synthesis/utilization therefore represents a potential means of rendering tumor cells more susceptible to different treatment options such as chemotherapy and radiotherapy.
Insights
Glutathione (GSH) is a key antioxidant in cells. While beneficial, high GSH levels can promote cancer progression and treatment resistance, suggesting it as a therapeutic target.
Area of Science:
- Biochemistry
- Cell Biology
- Oncology
Background:
- Glutathione (GSH) is the primary intracellular antioxidant, crucial for maintaining cellular redox homeostasis.
- GSH plays vital roles in detoxification, cysteine preservation, and influencing cancer cell therapeutic resistance.
- GSH metabolism exhibits dual roles in malignancies, impacting carcinogen detoxification and cell survival.
Purpose of the Study:
- To review recent findings on the role of glutathione in tumor initiation and progression.
- To elucidate the mechanisms by which GSH confers resistance to cancer treatments.
- To explore targeting GSH metabolism as a strategy to enhance cancer therapy efficacy.
Main Methods:
- Literature review of recent studies on glutathione's role in cancer.
- Analysis of mechanisms linking GSH to tumor progression and treatment resistance.
- Discussion of therapeutic strategies targeting GSH synthesis and utilization.
Main Results:
- Elevated GSH levels are associated with increased tumor progression and metastasis.
- GSH contributes to acquired resistance in cancer cells against therapies like chemotherapy and radiotherapy.
- Alterations in GSH metabolic pathways significantly affect cancer cell survival and treatment outcomes.
Conclusions:
- Glutathione's multifaceted role in cancer necessitates a deeper understanding of its metabolic pathways.
- Targeting GSH synthesis or utilization presents a promising strategy to overcome treatment resistance in various cancers.
- Modulating GSH levels could enhance the susceptibility of tumor cells to conventional therapies, improving patient outcomes.
Related Concept Videos
Treatment Resistant Cancers
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
What is Metabolism?
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Resistivity
Resistance

